Jump to content

Publication: Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial: Difference between revisions

From CAMIH
Created page with "{{Publication |Title=Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial |Topic=Green tea (EGCG) |Author=Kessels, J.; Voeten, L.; Nelemans, P.; Cleutjens, J.; Hillen, L. M.; Mosterd, K.; Kelleners-Smeets, N. W. J. |Year=2017 |Journal=JAMA dermatology |DOI=https://doi.org/10.1001/jamadermatol.2017.2529 |Authors Abstract=This randomized clinical trial compares topical sinecatechins ointment, 10%, vs. placebo in the treatme..."
 
No edit summary
 
Line 2: Line 2:
|Title=Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial
|Title=Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial
|Topic=Green tea (EGCG)
|Topic=Green tea (EGCG)
|Author=Kessels, J.; Voeten, L.; Nelemans, P.; Cleutjens, J.; Hillen, L. M.; Mosterd, K.; Kelleners-Smeets, N. W. J.
|Author=Kessels, J; Voeten, L; Nelemans, P; Cleutjens, J; Hillen, LM; Mosterd, K; Kelleners-Smeets, NWJ
|Year=2017
|Year=2017
|Journal=JAMA dermatology
|Journal=JAMA dermatology

Latest revision as of 13:59, 10 July 2024


Reference
Title Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial
Topic Green tea (EGCG)
Author Kessels, J, Voeten, L, Nelemans, P, Cleutjens, J, Hillen, LM, Mosterd, K, Kelleners-Smeets, NWJ
Year 2017
Journal JAMA dermatology
DOI https://doi.org/10.1001/jamadermatol.2017.2529

Author's Abstract The abstract and the information and conclusions contained therein were written by the authors of the publication.

This randomized clinical trial compares topical sinecatechins ointment, 10%, vs. placebo in the treatment of superficial basal cell carcinoma.



This publication is referenced in the following studies:

  1. Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial